CAR-T Meeting 2023 | The promise of novel multivalent gamma-delta T-cells in the treatment of cancers
Jürgen Kuball
• 10 Feb 2023
In this video, Jürgen Kuball, MD, PhD, Utrecht University, Utrecht, The Netherlands, briefly discusses the promise of novel gamma-delta (γδ) T-cells, which are being explored for the treatment of various cancers and have shown promising pre-clinical results. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Dr. Kuball reports grants from Gadeta, Novartis, and Miltenyi Biotech, and is the inventor on patents dealing with γδT cell-related aspects, as well as the co-founder and shareholder of Gadeta.
